Literature DB >> 20382434

Differential integrin expression by T lymphocytes: potential role in DMD muscle damage.

Fernanda Pinto-Mariz1, Luciana Rodrigues Carvalho, Wallace de Mello, Alexandra de Queiroz Campos Araújo, Márcia Gonçalves Ribeiro, Maria do Carmo Soares Alves Cunha, Thomas Voit, Gillian Butler-Browne, Suse Dayse Silva-Barbosa, Wilson Savino.   

Abstract

The expression and function of integrin-type extracellular matrix receptors, VLA-4 and VLA-5, and laminin receptor VLA-6 on the surface of CD3(+)CD4(+) and CD3(+)CD8(+) defined T cell populations was evaluated in the blood of Duchenne muscular dystrophy (DMD) patients and healthy individuals. Both the number of CD4(+) and CD8(+) T cell subsets expressing VLA-4 or VLA-5 and the fibronectin-driven T cell migration was significantly higher in DMD patients. These data indicate that interactions of VLA-4 and/or VLA-5 with fibronectin may drive T lymphocytes to specific niches within muscle, contributing to tissue damage and fibrosis in DMD patients. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382434     DOI: 10.1016/j.jneuroim.2010.03.006

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

1.  Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy.

Authors:  Inès Barthélémy; Fernanda Pinto-Mariz; Erica Yada; Loïc Desquilbet; Wilson Savino; Suse Dayse Silva-Barbosa; Anne-Marie Faussat; Vincent Mouly; Thomas Voit; Stéphane Blot; Gillian Butler-Browne
Journal:  Dis Model Mech       Date:  2014-09-26       Impact factor: 5.758

2.  Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.

Authors:  H Rabe; M Malmquist; C Barkman; S Östman; I Gjertsson; R Saalman; A E Wold
Journal:  Clin Exp Immunol       Date:  2019-04-08       Impact factor: 4.330

3.  Mouse basophils reside in extracellular matrix-enriched bone marrow niches which control their motility.

Authors:  Salete Smaniotto; Elke Schneider; Nicolas Goudin; Rachel Bricard-Rignault; François Machavoine; Mireille Dardenne; Michel Dy; Wilson Savino
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

4.  CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy.

Authors:  Fernanda Pinto-Mariz; Luciana Rodrigues Carvalho; Alexandra Prufer De Queiroz Campos Araujo; Wallace De Mello; Márcia Gonçalves Ribeiro; Maria Do Carmo Soares Alves Cunha; Pedro Hernan Cabello; Ingo Riederer; Elisa Negroni; Isabelle Desguerre; Mariana Veras; Erica Yada; Yves Allenbach; Olivier Benveniste; Thomas Voit; Vincent Mouly; Suse Dayse Silva-Barbosa; Gillian Butler-Browne; Wilson Savino
Journal:  Skelet Muscle       Date:  2015-12-10       Impact factor: 4.912

Review 5.  A Spotlight on T Lymphocytes in Duchenne Muscular Dystrophy-Not Just a Muscle Defect.

Authors:  Chantal A Coles; Ian Woodcock; Daniel G Pellicci; Peter J Houweling
Journal:  Biomedicines       Date:  2022-02-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.